The question arises which patients with T4 rectal cancer really need extensive surgery and who can safely be considered for an organ preserving approach.
Fruquintinib plus best supportive care for patients with metastatic colorectal cancer: Characterization of patients who had an overall survival of ≥10 months in the FRESCO-2 study. Updated analysis of ...
Surgery for rectal cancer is associated with a high rate of recurrence (50–70%) when the cancer is fixed on presentation. Neoadjuvant chemoradiation can reduce the tumor volume and pathologic ...
NOTE. Proposed changes (bold type) are based on rectal cancer pooled analysis, NCDB colon cancer analysis, and SEER rectal and colon cancer analyses. Abbreviations: AJCC, American Joint Committee on ...
Hosted on MSN1mon
Novel radiotracer identifies critical cancer biomarker, opens door to new therapeutic target for solid tumorsIt is commonly found in triple-negative breast cancer, colorectal cancer ... 18 F-AlF-RESCA-T4 and 18 F-AlF-RESCA-RT4. Preclinical imaging and blocking studies were performed on tumor-bearing ...
Despite recent advances in therapy, certain subtypes of colorectal cancer, such as those that are microsatellite instability ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results